Philips extends RESP offer deadline
This article was originally published in Clinica
Executive Summary
Philips has moved the expiration date of its offer for Respironics shares to March 6. The original deadline for the offer had been February 4, but this was extended to February 22. On expiration of the second deadline, the Dutch electronics group said it had acquired 63.7 million - or 82% - of outstanding Respironics shares. In December 2007, Philips agreed to buy the Murrysville, Pennsylvania-based home healthcare and respiratory device specialist for $66 per share (see Clinica No 1288, p 1).
You may also be interested in...
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
Irish Body Sets Out Five-Year Vision Strategy For Off-Patent Sector
With a focus on drug accessibility, supply chain resilience, and a balanced approach to sustainability, Medicines for Ireland “calls to action” with its five-year plan.
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.